# Endonovo Therapeutics, Inc. (ENDV)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ENDV/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -1.17M | $ -99.5K | $ 7.04M | $ -30.05M |
| 2025 | $ 0 | $ -2.23M | $ -18.4K | $ 6.91M | $ -28.87M |
| 2024 | $ 10.6K | $ -2.94M | $ 105.6K | $ 6.87M | $ -26.80M |
| 2023 | $ 151.6K | $ 7.49M | $ 131.8K | $ 7.07M | $ -24.11M |
| 2022 | $ 151.2K | $ -20.64M | $ -758.3K | $ 7.15M | $ -32.18M |
| 2021 | $ 86.9K | $ -3.69M | $ -1.17M | $ 7.18M | $ -15.77M |
| 2020 | $ 211.2K | $ -503.9K | $ -944.7K | $ 6.63M | $ -14.37M |
| 2019 | $ 400.3K | $ -22.35M | $ -3.28M | $ 6.86M | $ -20.50M |
| 2018 | $ 110.0K | $ -8.50M | $ -3.80M | $ 6.32M | $ -11.39M |
| 2017 | $ 0 | $ -14.56M | $ -4.03M | $ 4.74M | $ -9.55M |
| 2016 | $ 1.51M | $ -7.31M | $ -3.39M | $ 2.06M | $ -8.56M |
| 2015 | $ 0 | $ -7.24M | $ -1.44M | $ 1.55M | $ -7.59M |
| 2014 | $ 34.2K | $ -1.36M | $ -1.28M | $ 1.42M | $ -4.69M |
| 2013 | $ 32.6K | $ -4.11M | $ -359.0K | $ 756.9K | $ -4.13M |
| 2012 | $ 44.1K | $ -2.54M | $ -411.3K | N/A | $ -1.88M |
| 2011 | $ 29.4K | $ -58.8K | $ -73.5K | $ 930.0K | $ -430.0K |
| 2010 | $ 30.3K | $ -60.6K | $ 15.1K | $ 0 | $ 170.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.23 |
| Liabilities / Eq | -1.00 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/ENDV.md)
- [Charts](https://sponda.capital/en/ENDV/charts.md)
- [Compare](https://sponda.capital/en/ENDV/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.